Here you can find WACKER's most recent press releases.
Nov 23, 2020
CureVac and WACKER Sign Manufacturing Contract for CureVac’s COVID-19 Vaccine Candidate: CVnCoV
CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Wacker Chemie AG announced today that they had signed a contract for the manufacturing of CureVac’s COVID-19 vaccine candidate CVnCoV.
Oct 23, 2020
WACKER Institute for Silicon Chemistry The Royal Society of Chemistry publishes pioneering research on silicone crosslinking without precious metals
A special honor has been bestowed upon researchers from the WACKER Group and from the WACKER Institute for Silicon Chemistry at the Technical University of Munich, Germany.